Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Jazz Pharmaceuticals PLC    JAZZ   IE00B4Q5ZN47

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products

Jazz Pharmaceuticals Plc operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products.

The company has a diverse portfolio of products in the areas of narcolepsy, oncology, pain and psychiatry.

Its product portfolio includes: XYREM, ERWINAZETM, PRIALT, intrathecal infusion, FAZACLO and LUVOX CR. The company was founded on January 18, 2012 and is headquartered in Dublin, Ireland.

Number of employees : 810 persons.
Sales per Businesses
20122013Delta
USD (in Million)%USD (in Million)%
Specialty Pharmaceutical Products585.98100%872.42100% +32.83%
Sales per Regions
20122013Delta
USD (in Million)%USD (in Million)%
United States538.2291.8%792.5290.8% +32.09%
Europe38.596.6%61.847.1% +37.6%
All Other9.171.6%18.062.1% +49.23%
Ireland-----
Managers
NameAgeSinceTitle
Bruce C. Cozadd, MBA502012Chairman & Chief Executive Officer
Russell J. Cox512012Chief Operating Officer & Executive Vice President
Matthew P. Young, MBA442013Chief Financial Officer & Senior Vice President
Mark G. Eller, PhD-2012Senior VP-Research & Clinical Development
Jeffrey K. Tobias, MD582011Chief Medical Officer, EVP-Research & Development
Paul L. Berns472010Independent Director
Bryan C. Cressey, MBA642012Independent Director
Patrick G. Enright, MBA522012Independent Director
Seamus C. Mulligan522012Director
Ken W. O'Keefe, MBA472012Independent Director
Shareholders
NameShares%
Fidelity Management & Research Co. 8,390,072 13.9%
Putnam Investment Management LLC 7,873,483 13.0%
The Vanguard Group, Inc. 3,268,413 5.40%
Janus Capital Management LLC 3,087,530 5.10%
BlackRock Fund Advisors 2,739,237 4.53%
Westfield Capital Management Co. LP 1,996,359 3.30%
Lone Pine Capital LLC 1,788,607 2.96%
Wells Capital Management, Inc. 1,406,117 2.32%
BT Investment Management Ltd. (Investment Management) 1,392,130 2.30%
Seamus C. Mulligan 1,307,205 2.16%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Biopharmaceuticals
Advertisement
Sector Pharmaceuticals
Growth (Revenue) Profitability
GILEAD SCIENCES, ..
AMGEN, INC.
CELGENE CORPORATI..
ABBVIE INC
BIOGEN IDEC INC
ASTRAZENECA PLC
ALEXION PHARMACEU..
VERTEX PHARMACEUT..
UCB
GRIFOLS SA
JAZZ PHARMACEUTIC..
INDIVIOR PLC
CHONGQING ZHIFEI ..
-
CELLDEX THERAPEUT..
BEIJING TIANTAN B..
-
THERAVANCE INC
MEDY TOX INC
RELYPSA INC
-
WALVAX BIOTECHNOL..
-
ARIAD PHARMACEUTI..
Sector Pharmaceuticals
Company contact information
Jazz Pharmaceuticals Plc
Connaught House
One Burlington Road
4th floor
Dublin 4

Phone : +353.1.634.7800
Fax : +353.1.634.7850
Web : www.jazzpharma.com
© 2015 Factset   
Dynamic quotes  
ON
| OFF